IPAC-RS Symposium: The Global Regulatory Landscape and Advances in Digital Technology: Transforming the
OINDP-Patient Experience.
The COVID-19 pandemic caused the cancellation of RDD 2020 and the IPAC-RS Symposium in Palm Desert, California. Registered delegates from around the world received access to enhanced content on the RDD Conference Website.
About IPAC-RS
Click the icons below to learn more about IPAC-RS.
IPAC-RS Posters
-
Patient-Centric Considerations for PTIT: Addressing Unintended Consequences in the Draft 2018 Guidance
-
IPAC-RS Product Quality Demonstration Strategy Working Group
-
-
Designs for a Robust Outcome in Pharmacokinetic Bioequivalence Testing of Orally-Inhaled Drug Products with Batch-to-Batch Variability
-
IPAC-RS PK Batch-to-Batch Variability Working Group
-
-
Update from the Cascade Impactor Working Group
-
IPAC-RS Cascade Impactor Working Group
-
-
Sharing Information Across the Globe: IPAC-RS Global Regulatory Review and Outreach (GRRO)
-
GRRO Brazil, GRRO China, GRRO Europe and GRRO North America Working Groups
-
-
The IPAC-RS Inhaler Common Use Errors Matrix
-
IPAC-RS Devices Group
-
-
Review of the Population Bioequivalence Criterion (PBE)
-
The PBE and GRRO Brazil Working Groups
-
Excel
